Statistics
Publications
73
Citations
5.2K
H-Index
39
Active since
1993
Philip R. Kym is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and molecular pharmacology.
Publications per year
1993–2023
73
73
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 174 citations · Full text
1–5 of 73